Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor

Biochemistry

Volumn 35, Issue 5, 1996, Pages 1387-1396

  Boer, R ^a   Dichtl, M ^b   Borchers, C ^c   Ulrich, W R ^a   Marecek, J F ^d   Prestwich, G D ^d   Glossmann, H ^b   Striessnig, J ^e  

^a ALTANA PHARMA AG   (Germany)

^b A 6020   (Austria)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d STONY BROOK UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDROPYRIDINE DERIVATIVE; 2,6 DIMETHYL 4 (2 TRIFLUOROMETHYLPHENYL) 1,4 DIHYDROPYRIDINE 3,5 DICARBOXYLIC ACID [2 [3 (4 BENZOYLPHENYL)PROPIONYLAMINO]ETHYL] ESTER ETHYL ESTER; CYTOTOXIC AGENT; GLYCOPROTEIN P; NIGULDIPINE; RHODAMINE 123; UNCLASSIFIED DRUG; VINBLASTINE;

ARTICLE; DISSOCIATION CONSTANT; DRUG TRANSPORT; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; T LYMPHOCYTE;

BENZOPHENONES; BINDING SITES; BIOLOGICAL TRANSPORT; CALCIUM CHANNELS; DIHYDROPYRIDINES; DRUG RESISTANCE, MULTIPLE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR PROBES; P-GLYCOPROTEIN; PHOTOSENSITIZING AGENTS; VINBLASTINE;

EID: 0030069428     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi951912u     Document Type: Article

References (44)

1. Boer, R., Grassegger, A., Schudt, C., & Glossmann, H. (1989) Eur. J. Pharmacol. 172, 131.
2. Boer, R., Haas, S., & Schödl, A. (1994) Eur. J. Cancer 30A, 1117.
3. Borchers, C., Ulrich, W.-R., Klemm, K., Ise, W., Gekeler, V., Haas, S., Schödl, A., Conrad, J., Przybylski, M., & Boer, R. (1995) Mol. Pharmacol. 48, 21.
4. Cornwell, M. M., Gottesmann, M. M., & Pastan, I. H. (1986) J. Biol. Chem. 261, 7921.
5. Cornwall, M. M., Pastan, I., & Gottesmann, M. M. (1987) J. Biol. Chem. 262, 2166.
6. DeLean, A., Munson, P. J., & Rodbard, D. (1978) Am. J. Physiol. 4, E97.
7. Ferry, D. R., Rombusch, M., Goli, A., & Glossmann, H. (1984) FEBS Lett. 169, 112.
8. Ferry, D. R., Russell, M. A., & Cullen, M. H. (1992) Biochem. Biophys. Res. Commun. 188, 440.
9. Fleming, G. F., Amato, J. M., Agresti, M., & Safa, A. R. (1992) Cancer Chemother. Pharmacol. 29, 445.
10. Ford, J., & Hait, W. N. (1990) Pharmacol. Rev. 42, 155.
11. Foxwell, B. M. J., Mackie, A., Ling, V., & Ryffel, B. (1989) Mol. Pharmacol. 36, 543.
12. Friche, E., Demant, E. J. F., Sehested, M., & Nissen, N. I. (1993) Br. J. Cancer 67, 226.
13. Glossmann, H., & Striessnig, J. (1990) Rev. Physiol. Biochem. Pharmacol. 114, 1.
14. Gottesman, M. M., & Pastan, I. (1993) Annu. Rev. Biochem. 62, 385.
15. Hait, W. N., Gesmonde, J. F., Murren, J. R., Yang, J., Chen, H., & Reiss, M. (1993) Biochem. Pharmacol. 45, 401.
16. Hering, S., Savchenko, A., Strübing, C., Lakitsch, M., & Striessnig, J. (1993) Mol. Pharmacol. 43, 820.
17. Hofmann, J., Wolf, A., Spitaler, M., Böck, G., Drach, J., Ludescher, C., & Grunicke, H. (1992) J. Cancer Res. Clin. Oncol. 118, 361.
18. Horton, J. K., Thimmaiah, K. N., Harwood, F. C., Kuttesch, J. F., & Houghton, P. J. (1993) Mol. Pharmacol 44, 552.
19. Hyafil, F., Vergely, C., Du Vignaud, P., & Grand-Perret, T. (1993) Cancer Res. 53, 4595.
20. Jaffrezou, J.-P., Herbert, J.-M., Levade, T., Gau, M.-N., Chatelain, P., & Laurent, G. (1991) J. Biol. Chem. 266, 19858.
21. Kajiji, S., Talbot, F., Grizzuti, K., Van Dyke-Phillips, V., Agresti, M., Safa, A. R., & Gros, P. (1993) Biochemistry 32, 4185.
22. Kamiwatari, M., Nagata, Y., Kikuchi, H., Yoshimura, A., Sumizawa, T., Shudo, N., Salpda, R., Seto, K., & Akiyama, S. (1989) Cancer Res. 49, 3190.
23. Keller, R. P., Altermatt, H. J., Nooter, K., Poschmann, G., Laissue, J. A., Bollinger, P., & Hiestand, P. C. (1992) Int. J. Cancer 50, 593.
24. Knaus, H. G., Striessnig, J., Hering, S., Marrer, S., Schwenner, E., Höltje, H.-D., & Glossmann, H. (1992) Mol. Pharmacol. 41, 298.
25. Linden, J. (1982) J. Cyclic Nucleotide Res. 8, 163.
26. Loo, T. W., & Clarke, D. M. (1993) J. Biol. Chem. 268, 19965.
27. Lowry, O. H., Rosebrough, N. H., Farr, A. L., & Randall, F. J. (1951) J. Biol. Chem. J 93, 265.
28. Moebius, F. F., Burrows, G. G., Striessnig, J., & Glossmann, H. (1993) Mol. Pharmacol. 43, 139.
29. Moebius, F. F., Hanner, M., Knaus, H. G., Weber, F., Striessnig, J., & Glossmann, H. (1994) J. Biol. Chem. 269, 29314.
30. Mourey, R. J., Estevez, V. A., Marecek, J. F., Barrow, R. K., Prestwich, G. D., & Snyder, S. H. (1993) Biochemistry 32, 1719.
31. Olszewski, I. D., Dorman, G., Elliott, J. T., Hong, Y., Ahern, D. G., & Prestwich, G. D. (1995) Bioconjugate Chem. 6, 395.
32. Pastan, I., & Gottesman, M. M. (1991) Annu. Rev. Med. 42, 277.
33. Prinz, H., & Striessnig, J. (1993) J. Biol. Chem. 268, 18580.
34. Qian, X., & Beck, W. T. (1990) Cancer Res. 50, 1132.
35. Reymann, A., Looft, G., Woermann, C., Dietel, M., & Erttmann, R. (1993) Cancer Chemother. Pharmacol. 32, 25.
36. Safa, A. R., Glover, C. J., Sewell, J. L., Meyers, M. B., Biedler, J. L., & Felsted, R. L. (1987) J. Biol. Chem. 262, 7884.
37. Safa, A. R., Stern, R. K., Choi, K., Agresti, M., Tamai, I., Mehta, N. D., & Roninson, I. B. (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 7225.
38. Safa, A. R., Agresti, M., Bryk, D., & Tamai, I. (1994) Biochemistry 33, 256.
39. Stein, W. D., Cardarelli, C., Pastan, I , & Gottesmann, M. M. (1994) Mol. Pharmacol. 45, 763.
40. Striessnig, J., Moosburger, K., Goll, A , Ferry, D R., & Glossmann, H. (1986) Eur. J. Biochem. 161, 603.
41. Striessnig, J., Knaus, H. G., Grabner, M., Moosburger, K., Seitz, W., Lietz, H., & Glossmann, H. (1987) FEBS Lett 212, 247.
42. Tamai I , & Safa, A R (1991) J. Biol. Chem. 266, 16796.
43. Watanabe, T , Kalasz, H., Yabana, H., Kuniyasu, A., Mershon, J., Itagaki, K., Vaghy, P I , Naito, K., Nakayama, H., & Schwartz, A. (1993) FEBS Lett 334, 261.
44. Yoshimura, A , Kuwazuru, Y , Sumizawa, T., Ichikawa, M., Ikeda, S -I , Uda, T , & Akiyama, S -I. (1989) J. Biol. Chem. 264, 16282.